The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis

References

• Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29(2):221–232. doi:10.1016/j.bpg.2015.02.003
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma–evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111. doi:10.1038/nrclinonc.2017.157
   PubMed Web of Science ®Google Scholar
• Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353–1357. doi:10.1053/jhep.2001.25087
   PubMed Web of Science ®Google Scholar
• Lunsford KE, Javle M, Heyne K, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol. 2018;3(5):337–348. doi:10.1016/S2468-1253(18)30045-1
   PubMed Web of Science ®Google Scholar
• Yi SW, Kang DR, Kim KS, et al. Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer. Cancer Chemother Pharmacol. 2014;73(1):191–198. doi:10.1007/s00280-013-2340-5
   PubMed Web of Science ®Google Scholar
• Moustafa M, Fasolo E, Bassi D, et al. The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: a propensity score analysis. Eur J Surg Oncol. 2020;46(4):632–637. doi:10.1016/j.ejso.2019.11.502
   PubMed Web of Science ®Google Scholar
• Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–1289. doi:10.1016/j.jhep.2014.01.021
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Duffy AG, Makarova-Rusher OV, Greten TF. The case for immune-based approaches in biliary tract carcinoma. Hepatology. 2016;64(5):1785–1791. doi:10.1002/hep.28635
   PubMed Web of Science ®Google Scholar
• Cools-Lartigue J, Spicer J, McDonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013;123(8):3446–3458. doi:10.1172/JCI67484
   PubMed Web of Science ®Google Scholar
• Casadei Gardini A, Marisi G, Canale M, et al. Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival. Onco Targets Ther. 2018;11:6555–6567. doi:10.2147/OTT.S170836
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204–1212. doi:10.1158/1055-9965.EPI-14-0146
   PubMed Web of Science ®Google Scholar
• Prado CMM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of Chemotherapy Toxicity and Time to Tumor Progression in metastatic breast Cancer patients receiving Capecitabine Treatment. Clin Cancer Res. 2009;15:2920–2926. doi:10.1158/1078-0432.CCR-08-2242
   PubMed Web of Science ®Google Scholar
• Read JA, Choy ST, Beale PJ, et al. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006;55(1):78–85. doi:10.1207/s15327914nc5501_10
   PubMed Web of Science ®Google Scholar
• Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997;66(2):460S–463S. doi:10.1093/ajcn/66.2.460S
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
   PubMed Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553. doi:10.3390/ijms23179553
   PubMed Web of Science ®Google Scholar
• Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65(8):1369–1376. doi:10.1136/gutjnl-2015-309260
   PubMed Web of Science ®Google Scholar
• Chen X, Wang S, Yang J, et al. The predictive value of hematological inflammatory markers for acute kidney injury and mortality in adults with hemophagocytic Lymphohistiocytosis: a retrospective analysis of 585 patients. Int Immunopharmacol. 2023;122:110564. doi:10.1016/j.intimp.2023.110564
   PubMed Web of Science ®Google Scholar
• Mullen JL, Buzby GP, Matthews DC, et al. Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support. Ann Surg. 1980;192(5):604–613. doi:10.1097/00000658-198019250-00004
   PubMed Web of Science ®Google Scholar
• Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158. doi:10.1186/1471-2407-13-158
   PubMed Web of Science ®Google Scholar
• Kim H, Shahbal H, Parpia S, et al. Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies. J Clin Epidemiol. 2023;160:1–13. doi:10.1016/j.jclinepi.2023.05.015
   PubMed Web of Science ®Google Scholar
• Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36(27):4391–4400. doi:10.1002/sim.7501
   PubMed Web of Science ®Google Scholar
• Andersen PK, Keiding N. Interpretability and importance of functionals in competing risks and multistate models. Stat Med. 2012;31(11–12):1074–1088. doi:10.1002/sim.4385
   PubMed Web of Science ®Google Scholar
• Iglesias-Escudero M, Arias-González N, Martínez-Cáceres E. Regulatory cells and the effect of cancer immunotherapy. Mol Cancer. 2023;22(1):26. doi:10.1186/s12943-023-01714-0
   PubMed Web of Science ®Google Scholar
• Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450–465. doi:10.1016/j.ccell.2023.02.014
   PubMed Web of Science ®Google Scholar
• Giles JR, Globig AM, Kaech SM, et al. CD8+ T cells in the cancer-immunity cycle. Immunity. 2023;56(10):2231–2253. doi:10.1016/j.immuni.2023.09.005
   PubMed Web of Science ®Google Scholar
• Baessler A, Vignali DAA. T Cell Exhaustion. Annu Rev Immunol. 2024;42. doi:10.1146/annurev-immunol-090222-110914
   Google Scholar
• Chen S, Saeed AFUH, Liu Q, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207. doi:10.1038/s41392-023-01452-1
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149–163. doi:10.2217/fon.09.136
   PubMed Web of Science ®Google Scholar
• Siracusa F, Tintelnot J, Cortesi F, et al. Diet and immune response: how today’s plate shapes tomorrow’s health. Trends Immunol. 2023;2023:8.
   Google Scholar
• Buzby GP, Mullen JL, Matthews DC, et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139:160–167. doi:10.1016/0002-9610(80)90246-9
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–1005.
   PubMedGoogle Scholar
• Sun K, Chen S, Xu J, et al. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2014;140:1537–1549. doi:10.1007/s00432-014-1714-3
   PubMed Web of Science ®Google Scholar
• Lamarca A, Santos-Laso A, Utpatel K, et al. Liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system. Hepatology. 2021;73(6):2311–2325. doi:10.1002/hep.31598
   PubMed Web of Science ®Google Scholar
• Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2014;18(7):1284–1291. doi:10.1007/s11605-014-2533-1
   PubMed Web of Science ®Google Scholar
• Cillo U, Spolverato G, Vitale A, et al. Liver resection for advanced intrahepatic cholangiocarcinoma: a cost-utility analysis. World J Surg. 2015;39:2500–2509. doi:10.1007/s00268-015-3150-1
   PubMed Web of Science ®Google Scholar
• de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140–3145. doi:10.1200/JCO.2011.35.6519
   PubMed Web of Science ®Google Scholar
• Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254(5):824–829. doi:10.1097/SLA.0b013e318236c21d
   PubMed Web of Science ®Google Scholar
• Kim Y, Moris DP, Zhang XF, et al. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol. 2017;116(6):643–650. doi:10.1002/jso.24720
   PubMed Web of Science ®Google Scholar
• Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, Phase 3 study. Lancet Oncol. 2019;20(5):663–673. doi:10.1016/S1470-2045(18)30915-X
   PubMed Web of Science ®Google Scholar
• Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: a comprehensive literature review. Cancer Treat Res Commun. 2021;27:100354. doi:10.1016/j.ctarc.2021.100354
   PubMedGoogle Scholar
• Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149(6):565–574. doi:10.1001/jamasurg.2013.5137
   PubMed Web of Science ®Google Scholar
• Miura JT, Johnston FM, Tsai S, et al. Chemotherapy for Surgically Resected Intrahepatic Cholangio- carcinoma. Ann Surg Oncol. 2015;22(11):3716–3723. doi:10.1245/s10434-015-4501-8
   PubMed Web of Science ®Google Scholar
• Altman AM, Kizy S, Marmor S, et al. Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus? Hepatobiliary Surg Nutr. 2020;9(5):577–586. doi:10.21037/hbsn.2019.06.12
   PubMed Web of Science ®Google Scholar
• Reames BN, Bagante F, Ejaz A, et al. Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis. HPB. 2017;19(10):901–909. doi:10.1016/j.hpb.2017.06.008
   PubMed Web of Science ®Google Scholar